tirzepatide discontinuation Comparison of versus placebo for safety outcomes: (1) Do You Have to Taper

The medication itself isn't necessarily the culprit so much as the speed and scale of the weight loss

Exenatide: from the Gila Monster to the Pharmacy. PubMed

MASLD indicates the presence of hepatic steatosis with one or more cardiometabolic risk factors in the absence of other causes of hepatic steatosis, such as drug-induced or alcohol-related steatosis, for example

GLP 1 receptor agonists addressed multiple aspects of glucose homeostasis by enhancing glucose dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety

But there is another practical barrier that patients know well before they reach the pharmacy counter: cost

Site rotation between injections helps prevent localized reactions and ensures consistent absorption